The Weinberg Group has joined ProPharma Group Regulatory Sciences

For over 35 years, The Weinberg Group’s FDA consultants have ensured clients like you achieve their drug and device development goals. The Weinberg Group’s expert regulatory consultants have now joined ProPharma Group; together forming the world’s leading provider of regulatory services for clients seeking compliance consulting with the FDA, EMA, and national agencies throughout Europe.
Our experienced team of FDA and EMA consultants can work with you to develop regulatory strategies; prepare submissions; and remediate, maintain, and improve regulatory compliance.
See Our Expanded Services
Supporting successful outcomes
We develop product development and regulatory strategies based on a solid scientific foundation, helping to ensure regulatory and market success from pre-approval of your product or medical device through post-approval launch, line extensions, and maintaining optimal regulatory status for both the FDA and EMA.

Your single-source service provider
ProPharma Group is the global, independent provider of regulatory sciences, clinical research solutions, life science consulting, pharmacovigilance, and medical information services serving pharmaceutical, biotechnology, and medical device companies.